Showing 35,233 results

Filters
PrEP programmes & uptake

Black Africans in UK have limited knowledge of PrEP despite ongoing risk

News
10 May 2021
HIV treatment

Tenofovir disoproxil fumarate Factsheet

About HIV
May 2021
Starting treatment

Same-day ART initiation linked to increased risk of negative outcomes

News
7 May 2021
PrEP policies & guidelines

UK: MP and National Pharmacy Association urge NHS to allow pharmacy provision of HIV drug PrEP

Editor's pick
Chemist + Druggist
6 May 2021
The search for an HIV prevention vaccine

The four-decade quest for an HIV vaccine yields new hope

Editor's pick
National Geographic
6 May 2021
Human rights

Uganda passes bill criminalising same-sex relationships and sex work

Editor's pick
The Guardian
6 May 2021
Human rights

Uganda’s Sexual Offences law a step back for HIV and human rights

Editor's pick
HIV Justice Network
6 May 2021
Finance & funding

At Nearly $706 Million, 2019 Marked the Highest Level of Philanthropic HIV Funding—with a Caveat

Editor's pick
Funders Concerned About AIDS
6 May 2021

Oxford/AstraZeneca COVID-19 vaccine – HIV update, 5 May 2021

May 2021
Activism & civil society

Patrick O’Connell, 67, Dies; Raised Awareness of AIDS With Art

Editor's pick
New York Times
5 May 2021
HIV in the arts & media

A New Testament to the Fury and Beauty of Activism During the AIDS Crisis

Editor's pick
New York Times
5 May 2021
Vaccinations & immunisations

HIV status does not affect immune responses to Oxford/AstraZeneca vaccine, two studies show

News
5 May 2021
Coronavirus

Fewer COVID-19 infections in people with HIV in San Francisco, but weaker antibody responses after infection

News
5 May 2021
Injectable & long-acting PrEP

ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV

Editor's pick
ViiV Healthcare press release
4 May 2021
Improving HIV care

‘Gamechanger’: Uganda launches drone delivering HIV drugs to remote islands

Editor's pick
The Guardian
4 May 2021
Pharmaceutical industry

Gilead's $1.5B in remdesivir sales help buoy worse-than-expected declines for mainstay HIV, hepatitis C drugs

Editor's pick
FiercePharma
4 May 2021
Retention & linkage to care

Model identifies variables associated with missing health care visits for HIV

Editor's pick
Healio
4 May 2021
Treatment guidelines

Updated recommendations on service delivery for the treatment and care of people living with HIV

Editor's pick
World Health Organization
4 May 2021
Access to healthcare

Big drops in the cost of antiretroviral medicines, but COVID-19 threatens further reductions

Editor's pick
UNAIDS
4 May 2021
Ageing & HIV

Our Days Are Numbered

Editor's pick
POZ
4 May 2021
Drug policy & policing

US: Do public health officials need to be political activists? A fight over an HIV crisis renews the question

Editor's pick
STAT
4 May 2021
Harm reduction

‘The last brave thing that happened’: How the injecting room led the way on drug reform in Australia

Editor's pick
Sydney Morning Herald
4 May 2021
Cardiovascular disease

Use of beta-blockers to treat high blood pressure in people with HIV associated with poorer cardiovascular outcomes

News
4 May 2021
Hepatitis C symptoms & diagnosis

Hepatitis C testing in gay and bisexual men with HIV below target, US study finds

News
3 May 2021